Novartis seeks to collaborate with Healthcare Professionals and Healthcare Organizations in the interest of patients. As an industry we make payments or ‘transfers of value’ to Healthcare Professionals and Organizations to compensate them for the time spent working with us.
Bringing greater transparency to this already well-regulated relationship builds understanding of this collaboration. We believe that openly communicating payments helps foster trust with patients, Healthcare Professionals, and government officials and supports our overall commitment to data transparency and high ethical business standards. Novartis has long been dedicated to improving clinical trial data transparency and discloses relationships with patient organizations.
In several countries, we publish payments to Healthcare Professionals and Organizations in line with local laws or regulations.